Thrombin time testing mainly measures how long it takes for soluble fibrinogen to turn into fibrin threads. It evaluates the time required for the blood's plasma to form a clot after adding a standard amount of thrombin to the plasma. The test is conducted by reclassifying citrated plasma and adding thrombin. The time required to measure clot formation is in seconds.
The global Thrombin Time Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Thrombin Time Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin Time Testing.
Report Scope
The Thrombin Time Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thrombin Time Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin Time Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Danaher
Siemens Healthcare GmbH
Thermo Fisher Scientific
HORIBA, Ltd
NIHON KOHDEN CORPORATION
F. Hoffmann-La Roche Ltd
A&T Corporation
Helena Laboratories Corporation
BPC BioSed S.R.L
Meril Life Sciences Pvt. Ltd
Haemonetics Corporation
ACON Laboratories, Inc
Coagulation Sciences LLC
Shenzhen Micropoint Biotechnologies Co., Ltd
Segment by Type
Consumables
Instrument
Segment by Application
Hospital
Specialist Clinic
O ther
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thrombin Time Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thrombin Time Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Thrombin Time Testing Market Overview
1.1 Product Overview and Scope of Thrombin Time Testing
1.2 Thrombin Time Testing Segment by Type
1.2.1 Global Thrombin Time Testing Market Value Comparison by Type (2024-2030)
1.2.2 Consumables
1.2.3 Instrument
1.3 Thrombin Time Testing Segment by Application
1.3.1 Global Thrombin Time Testing Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 O ther
1.4 Global Thrombin Time Testing Market Size Estimates and Forecasts
1.4.1 Global Thrombin Time Testing Revenue 2019-2030
1.4.2 Global Thrombin Time Testing Sales 2019-2030
1.4.3 Global Thrombin Time Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Thrombin Time Testing Market Competition by Manufacturers
2.1 Global Thrombin Time Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global Thrombin Time Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Thrombin Time Testing Average Price by Manufacturers (2019-2024)
2.4 Global Thrombin Time Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Thrombin Time Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thrombin Time Testing, Product Type & Application
2.7 Thrombin Time Testing Market Competitive Situation and Trends
2.7.1 Thrombin Time Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thrombin Time Testing Players Market Share by Revenue
2.7.3 Global Thrombin Time Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thrombin Time Testing Retrospective Market Scenario by Region
3.1 Global Thrombin Time Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Thrombin Time Testing Global Thrombin Time Testing Sales by Region: 2019-2030
3.2.1 Global Thrombin Time Testing Sales by Region: 2019-2024
3.2.2 Global Thrombin Time Testing Sales by Region: 2025-2030
3.3 Global Thrombin Time Testing Global Thrombin Time Testing Revenue by Region: 2019-2030
3.3.1 Global Thrombin Time Testing Revenue by Region: 2019-2024
3.3.2 Global Thrombin Time Testing Revenue by Region: 2025-2030
3.4 North America Thrombin Time Testing Market Facts & Figures by Country
3.4.1 North America Thrombin Time Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Thrombin Time Testing Sales by Country (2019-2030)
3.4.3 North America Thrombin Time Testing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Thrombin Time Testing Market Facts & Figures by Country
3.5.1 Europe Thrombin Time Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Thrombin Time Testing Sales by Country (2019-2030)
3.5.3 Europe Thrombin Time Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thrombin Time Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Thrombin Time Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Thrombin Time Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific Thrombin Time Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Thrombin Time Testing Market Facts & Figures by Country
3.7.1 Latin America Thrombin Time Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Thrombin Time Testing Sales by Country (2019-2030)
3.7.3 Latin America Thrombin Time Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thrombin Time Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Thrombin Time Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Thrombin Time Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Thrombin Time Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Thrombin Time Testing Sales by Type (2019-2030)
4.1.1 Global Thrombin Time Testing Sales by Type (2019-2024)
4.1.2 Global Thrombin Time Testing Sales by Type (2025-2030)
4.1.3 Global Thrombin Time Testing Sales Market Share by Type (2019-2030)
4.2 Global Thrombin Time Testing Revenue by Type (2019-2030)
4.2.1 Global Thrombin Time Testing Revenue by Type (2019-2024)
4.2.2 Global Thrombin Time Testing Revenue by Type (2025-2030)
4.2.3 Global Thrombin Time Testing Revenue Market Share by Type (2019-2030)
4.3 Global Thrombin Time Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Thrombin Time Testing Sales by Application (2019-2030)
5.1.1 Global Thrombin Time Testing Sales by Application (2019-2024)
5.1.2 Global Thrombin Time Testing Sales by Application (2025-2030)
5.1.3 Global Thrombin Time Testing Sales Market Share by Application (2019-2030)
5.2 Global Thrombin Time Testing Revenue by Application (2019-2030)
5.2.1 Global Thrombin Time Testing Revenue by Application (2019-2024)
5.2.2 Global Thrombin Time Testing Revenue by Application (2025-2030)
5.2.3 Global Thrombin Time Testing Revenue Market Share by Application (2019-2030)
5.3 Global Thrombin Time Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Thrombin Time Testing Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Danaher Thrombin Time Testing Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Siemens Healthcare GmbH
6.3.1 Siemens Healthcare GmbH Corporation Information
6.3.2 Siemens Healthcare GmbH Description and Business Overview
6.3.3 Siemens Healthcare GmbH Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Siemens Healthcare GmbH Thrombin Time Testing Product Portfolio
6.3.5 Siemens Healthcare GmbH Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Scientific Thrombin Time Testing Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 HORIBA, Ltd
6.5.1 HORIBA, Ltd Corporation Information
6.5.2 HORIBA, Ltd Description and Business Overview
6.5.3 HORIBA, Ltd Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HORIBA, Ltd Thrombin Time Testing Product Portfolio
6.5.5 HORIBA, Ltd Recent Developments/Updates
6.6 NIHON KOHDEN CORPORATION
6.6.1 NIHON KOHDEN CORPORATION Corporation Information
6.6.2 NIHON KOHDEN CORPORATION Description and Business Overview
6.6.3 NIHON KOHDEN CORPORATION Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NIHON KOHDEN CORPORATION Thrombin Time Testing Product Portfolio
6.6.5 NIHON KOHDEN CORPORATION Recent Developments/Updates
6.7 F. Hoffmann-La Roche Ltd
6.6.1 F. Hoffmann-La Roche Ltd Corporation Information
6.6.2 F. Hoffmann-La Roche Ltd Description and Business Overview
6.6.3 F. Hoffmann-La Roche Ltd Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Ltd Thrombin Time Testing Product Portfolio
6.7.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.8 A&T Corporation
6.8.1 A&T Corporation Corporation Information
6.8.2 A&T Corporation Description and Business Overview
6.8.3 A&T Corporation Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 A&T Corporation Thrombin Time Testing Product Portfolio
6.8.5 A&T Corporation Recent Developments/Updates
6.9 Helena Laboratories Corporation
6.9.1 Helena Laboratories Corporation Corporation Information
6.9.2 Helena Laboratories Corporation Description and Business Overview
6.9.3 Helena Laboratories Corporation Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Helena Laboratories Corporation Thrombin Time Testing Product Portfolio
6.9.5 Helena Laboratories Corporation Recent Developments/Updates
6.10 BPC BioSed S.R.L
6.10.1 BPC BioSed S.R.L Corporation Information
6.10.2 BPC BioSed S.R.L Description and Business Overview
6.10.3 BPC BioSed S.R.L Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BPC BioSed S.R.L Thrombin Time Testing Product Portfolio
6.10.5 BPC BioSed S.R.L Recent Developments/Updates
6.11 Meril Life Sciences Pvt. Ltd
6.11.1 Meril Life Sciences Pvt. Ltd Corporation Information
6.11.2 Meril Life Sciences Pvt. Ltd Thrombin Time Testing Description and Business Overview
6.11.3 Meril Life Sciences Pvt. Ltd Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Meril Life Sciences Pvt. Ltd Thrombin Time Testing Product Portfolio
6.11.5 Meril Life Sciences Pvt. Ltd Recent Developments/Updates
6.12 Haemonetics Corporation
6.12.1 Haemonetics Corporation Corporation Information
6.12.2 Haemonetics Corporation Thrombin Time Testing Description and Business Overview
6.12.3 Haemonetics Corporation Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Haemonetics Corporation Thrombin Time Testing Product Portfolio
6.12.5 Haemonetics Corporation Recent Developments/Updates
6.13 ACON Laboratories, Inc
6.13.1 ACON Laboratories, Inc Corporation Information
6.13.2 ACON Laboratories, Inc Thrombin Time Testing Description and Business Overview
6.13.3 ACON Laboratories, Inc Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ACON Laboratories, Inc Thrombin Time Testing Product Portfolio
6.13.5 ACON Laboratories, Inc Recent Developments/Updates
6.14 Coagulation Sciences LLC
6.14.1 Coagulation Sciences LLC Corporation Information
6.14.2 Coagulation Sciences LLC Thrombin Time Testing Description and Business Overview
6.14.3 Coagulation Sciences LLC Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Coagulation Sciences LLC Thrombin Time Testing Product Portfolio
6.14.5 Coagulation Sciences LLC Recent Developments/Updates
6.15 Shenzhen Micropoint Biotechnologies Co., Ltd
6.15.1 Shenzhen Micropoint Biotechnologies Co., Ltd Corporation Information
6.15.2 Shenzhen Micropoint Biotechnologies Co., Ltd Thrombin Time Testing Description and Business Overview
6.15.3 Shenzhen Micropoint Biotechnologies Co., Ltd Thrombin Time Testing Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shenzhen Micropoint Biotechnologies Co., Ltd Thrombin Time Testing Product Portfolio
6.15.5 Shenzhen Micropoint Biotechnologies Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thrombin Time Testing Industry Chain Analysis
7.2 Thrombin Time Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thrombin Time Testing Production Mode & Process
7.4 Thrombin Time Testing Sales and Marketing
7.4.1 Thrombin Time Testing Sales Channels
7.4.2 Thrombin Time Testing Distributors
7.5 Thrombin Time Testing Customers
8 Thrombin Time Testing Market Dynamics
8.1 Thrombin Time Testing Industry Trends
8.2 Thrombin Time Testing Market Drivers
8.3 Thrombin Time Testing Market Challenges
8.4 Thrombin Time Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
Danaher
Siemens Healthcare GmbH
Thermo Fisher Scientific
HORIBA, Ltd
NIHON KOHDEN CORPORATION
F. Hoffmann-La Roche Ltd
A&T Corporation
Helena Laboratories Corporation
BPC BioSed S.R.L
Meril Life Sciences Pvt. Ltd
Haemonetics Corporation
ACON Laboratories, Inc
Coagulation Sciences LLC
Shenzhen Micropoint Biotechnologies Co., Ltd
听
听
*If Applicable.
